XML 13 R3.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Revenue $ 385.6 $ 316.3
Cost of revenue [1],[2] 98.4 120.6
Gross profit 287.2 195.7
Operating expenses    
Research and development [1],[2] 150.0 378.5
Sales and marketing [1],[2] 101.5 157.0
General and administrative [1],[2] 57.0 126.1
Total operating expenses [1],[2] 308.5 661.6
Loss from operations (21.3) (465.9)
Interest income (expense), net 3.7 (1.2)
Other income, net 4.2 3.4
Loss before income taxes (13.4) (463.7)
Benefit from (provision for) income taxes 5.7 (1.8)
Net loss $ (7.7) $ (465.5)
Net loss per share attributable to common stockholders, basic and diluted (in dollars per share) $ (0.02) $ (2.13)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares) 410.5 218.8
[1] During the three months ended March 31, 2018, the Company recognized the cumulative unrecognized stock-based compensation of $418.7 million related to two-tier restricted stock units upon the effectiveness of the registration statement for the Company's IPO. See Note 1, "Description of the Business and Summary of Significant Accounting Policies" for further information.
[2] Includes stock-based compensation as follows (in millions): for the three months ended June 30, 2018 and 2017: Cost of revenues of 3.0 million and 37.8 million . Research and development of 30.5 million and 282.9 million. Sales and marketing 7.1 million and 72.4 million. General and administrative of 15.0 million and 93.4 million, respectively.